Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Microbicides for Topical HIV Immunoprophylaxis: Current Status and Future Prospects

Version 1 : Received: 14 May 2024 / Approved: 16 May 2024 / Online: 16 May 2024 (08:33:39 CEST)

A peer-reviewed article of this Preprint also exists.

Zhernov, Y.V.; Petrova, V.O.; Simanduyev, M.Y.; Shcherbakov, D.V.; Polibin, R.V.; Mitrokhin, O.V.; Basov, A.A.; Zabroda, N.N.; Vysochanskaya, S.O.; Al-khaleefa, E.; Pashayeva, K.R.; Feyziyeva, N.Y. Microbicides for Topical HIV Immunoprophylaxis: Current Status and Future Prospects. Pharmaceuticals 2024, 17, 668. Zhernov, Y.V.; Petrova, V.O.; Simanduyev, M.Y.; Shcherbakov, D.V.; Polibin, R.V.; Mitrokhin, O.V.; Basov, A.A.; Zabroda, N.N.; Vysochanskaya, S.O.; Al-khaleefa, E.; Pashayeva, K.R.; Feyziyeva, N.Y. Microbicides for Topical HIV Immunoprophylaxis: Current Status and Future Prospects. Pharmaceuticals 2024, 17, 668.

Abstract

Microbicides, topical antiseptic agents, and a revolutionary advance in HIV prevention aim to prevent the entry of infectious agents into the human body, thus stopping the sexual transmission of HIV and other sexually transmitted diseases. Microbicides represent the promise of a new age in preventive measures against one of the world's most pressing health challenges. In addition to their direct antiviral effects during HIV transmission, microbicides also influence vaginal mucosal immunity. This article reviews microbicides by presenting different drug classifications and highlighting significant representatives from each group. It also explains their mechanisms of action and presents information about vaginal mucosal immune responses, emphasizing the critical role they play in responding to HIV during sexual transmission. For each chemical compound, the article provides a brief overview of relevant preclinical and clinical research, emphasizing their potential as microbicides.The article offers insights into the multifaceted impact of microbicides, which signify a pivotal step forward in the pursuit of effective and accessible pre-exposure prophylaxis (PrEP).

Keywords

HIV; AIDS; mucosal immunity; microbicides; pre-exposure prophylaxis

Subject

Medicine and Pharmacology, Epidemiology and Infectious Diseases

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.